Rise In Organ Transplantation And Shortage Of Donors Will Drive Artificial Organs Market Demand – Fact.MR Study
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra corporeal, where blood is temporarily processed outside patient’s body. The range of devices that form artificial organs are at present limited in use. However, research and development activities have involved devices that have active biologic, or mechanical functions.
Request For Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=3095
Artificial Organs Market Segmentation
Based on the type, the artificial organs market is segmented into
- Artificial Heart
- Artificial Eye
- Artificial Pancreas
- Artificial Ear
- Artificial Urinary Bladder
On the basis of technology, the artificial organs market is segmented into
- Implantable Technology
- Wearable Technology
The research report presents a comprehensive assessment of the artificial organs market and contains thoughtful insights, facts, and historical data and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to artificial organs market segments such as geographies, application and industry.
Enquiry Before Buying – https://www.factmr.com/connectus/sample?flag=EB&rep_id=3095
Artificial Organs Market: Notable Highlights
- Owing to high fatalities on account of kidney disease, the Trump administration is focusing on improving kidney disease care, along with exploring the development of artificial kidneys. The Department of Health and Human Services will also focus on how more organs can be provided for kidney transplants.
- The team of scientists in Germany from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has created artificial organs for cancer patients to replace damaged organs due to chemotherapy. The artificial ovaries created by the team has been created using biodegradable material and gelatine that can mimic the natural organ and can also restore fertility in women.
- CARMAT recently announced update on its clinical progress and latest developments. The company announced positive results for first part of Pivotal study, on-going enrollment of second cohort of patients, and the company is also assuming the FDA validates its application- the launch of implants in patients in America by 2019 end.
- Fresenius Medical Care has acquired NxStage Medical, a home dialysis device maker for $2 billion in order to accelerate its move towards home treatment.
Some of the leading players in the artificial organs market are Cochlear Ltd., Boston Scientific Corporation, Dexcom, Inc., CARMAT, Oticon Medical, Advanced Bionics AG and affiliates, Fresenius Medical Care AG & Co. KGaA, MED-EL, Medtronic plc, SynCardia Systems, LLC, and Retina Implant AG.
Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3095
Artificial Organs Market Dynamics
Rise in Organ Transplantation and Shortage of Available Donors to Drive Artificial Organs Market
From several years now, replacing the failing human organ has been an important element in healthcare. With modern medical techniques, organ transplantation has overcome major limitations and achieved success. However, one limitation in organ transplantation is the lack of suitable donors and organ shortage is the biggest challenge. According to the American Transplant Foundation, around 115,000 people in the US are currently on the list for a lifesaving organ transplant.
With the rise in the number of people for organ transplant, scientists are focusing on developing safer and cheaper pathways to create artificial organs that can reduce the wait for organ transplant for patients. Demand for artificial organs is likely to grow significantly owing to the rise in lifestyle diseases that lead to the need for organ transplantation in particular for heart and kidney.
Increasing Use of Advanced Biomaterials in Artificial Organs
Artificial organs have become imperative with a worldwide rise in organ transplants exceeding available organ donors. Recent advances in biomaterials have generated range of devices and materials for use through the implantation or outside the body to replace the organ that may have been lost due to injury or disease. Most commonly used biomaterials are nanocomposits, polymers, and ceramics. However, with advanced technologies and materials new biomaterials are being developed in the artificial organs market.
Natural biomaterials including collagen, silk, processed human and animal tissues are also being used on a large scale. The emergence of tissue engineering targets the regeneration of damaged tissue in body by combining cells in body with high porous scaffold made using the biomaterials. 3D printing for biomaterials to make artificial organs is also gaining traction. Rather than using mechanical components for artificial organs, new organs are being developed from lab cultured cells.
Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/
Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:
Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031
Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031
Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031
Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com